The renewed interest in psilocybin for the treatment of psychiatric conditions has highlighted a lack of robustness and reproducibility in reports of its behavioural effects. In this study, Lu et al. coordinated five independent laboratories to assess the previously reported acute and persistent behavioural effects of psilocybin in mice using standardized behavioural assays that are commonly used to assess depression and anxiety-like phenotypes in animal models.
In line with previous reports, the acute effects of psilocybin (detected in the first 15 min after administration) — increasing anxiety-related avoidance and decreasing fear expression — were observed consistently across laboratories. However, psilocybin’s reported persistent effects — including the alleviation of anxiety-like and depression-related behaviours, facilitation of fear extinction, enhanced social preference and reopening of a critical period for social reward learning in adult mice — were inconsistently observed.
Read full article: https://www.nature.com/articles/s41583-026-01109-2
















